|
| 36765747 | Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer. | Cancers (Basel) | 2023 |
| 36661662 | Combining Molecular Subtypes with Multivariable Clinical Models Has the Potential to Improve Prediction of Treatment Outcomes in Prostate Cancer at Diagnosis. | Curr Oncol | 2022 |
| 35454901 | A Model to Detect Significant Prostate Cancer Integrating Urinary Peptide and Extracellular Vesicle RNA Data. | Cancers (Basel) | 2022 |
| 35450835 | Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups. | Eur Urol Oncol | 2022 |
| 33925381 | Integration of Urinary EN2 Protein & Cell-Free RNA Data in the Development of a Multivariable Risk Model for the Detection of Prostate Cancer Prior to Biopsy. | Cancers (Basel) | 2021 |
| 32203215 | A novel stratification framework for predicting outcome in patients with prostate cancer. | Br J Cancer | 2020 |
| 31779479 | Methodology for the at-home collection of urine samples for prostate cancer detection. | Biotechniques | 2020 |
| 32153047 | Development of a multivariable risk model integrating urinary cell DNA methylation and cell-free RNA data for the detection of significant prostate cancer. | Prostate | 2020 |
| 31106513 | A four-group urine risk classifier for predicting outcomes in patients with prostate cancer. | BJU Int | 2019 |
| 30801051 | epiCaPture: A Urine DNA Methylation Test for Early Detection of Aggressive Prostate Cancer. | JCO Precis Oncol | 2019 |
| 28753852 | DESNT: A Poor Prognosis Category of Human Prostate Cancer. | Eur Urol Focus | 2018 |
| 30470249 | A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer. | Clin Epigenetics | 2018 |
| 28945760 | Appraising the relevance of DNA copy number loss and gain in prostate cancer using whole genome DNA sequence data. | PLoS Genet | 2017 |
| 28292578 | Corrigendum to "Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study" [EBioMedicine 2 (9) (2015) 1133-1144]. | EBioMedicine | 2017 |
| 28419548 | Detection of prostate cancer-specific transcripts in extracellular vesicles isolated from post-DRE urine. | Prostate | 2017 |
| 26455355 | Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients. | Eur Urol | 2016 |
| 25586381 | Mutation detection in formalin-fixed prostate cancer biopsies taken at the time of diagnosis using next-generation DNA sequencing. | J Clin Pathol | 2015 |
| 26501111 | Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study. | EBioMedicine | 2015 |
| 26162314 | Building Data-Driven Pathways From Routinely Collected Hospital Data: A Case Study on Prostate Cancer. | JMIR Med Inform | 2015 |
| 26018901 | Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 25664317 | Biomarker and translational prostate cancer research. | Biomed Res Int | 2015 |
| 25730763 | Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. | Nat Genet | 2015 |
| 24481405 | Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer. | Br J Cancer | 2014 |
| 23774836 | The present and future of prostate cancer urine biomarkers. | Int J Mol Sci | 2013 |
| 23695019 | Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer. | Br J Cancer | 2013 |
| 22460813 | Novel, gross chromosomal alterations involving PTEN cooperate with allelic loss in prostate cancer. | Mod Pathol | 2012 |
| 23059046 | Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. | Lancet Oncol | 2012 |
| 23144797 | Multi-purpose utility of circulating plasma DNA testing in patients with advanced cancers. | PLoS One | 2012 |
| 22833462 | Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer. | Genes Chromosomes Cancer | 2012 |
| 21383285 | Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies. | J Clin Oncol | 2011 |
| 20104229 | Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer. | Br J Cancer | 2010 |
| 20177423 | The identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancer. | Prostate Cancer Prostatic Dis | 2010 |
| 20145164 | Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsies. | Clin Cancer Res | 2010 |
| 19040532 | Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer. | BJU Int | 2009 |
| 19657377 | ETS gene fusions in prostate cancer. | Nat Rev Urol | 2009 |
| 19707199 | Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement. | Br J Cancer | 2009 |
| 19638540 | An improved method for constructing tissue microarrays from prostate needle biopsy specimens. | J Clin Pathol | 2009 |
| 19544327 | A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies. | Prostate | 2009 |
| 17637754 | Duplication of the fusion of TMPRSS2 to ERG sequences identifies fatal human prostate cancer. | Oncogene | 2008 |
| 18594527 | Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. | Br J Cancer | 2008 |
| 18645193 | Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven. | J Clin Oncol | 2008 |
| 18274524 | Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays. | Nat Protoc | 2008 |
| 17922029 | Complex patterns of ETS gene alteration arise during cancer development in the human prostate. | Oncogene | 2008 |
| 18165275 | Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip Human Exon 1.0 ST arrays. | J Mol Diagn | 2008 |
| 17244020 | A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. | Differentiation | 2007 |
| 17043636 | Diversity of TMPRSS2-ERG fusion transcripts in the human prostate. | Oncogene | 2007 |
| 16546166 | Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. | Exp Cell Res | 2006 |
| 16849266 | Identification of prognostic signatures in breast cancer microarray data using Bayesian techniques. | J R Soc Interface | 2006 |
| 16938365 | Nuclear overexpression of the E2F3 transcription factor in human lung cancer. | Lung Cancer | 2006 |
| 15583692 | Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. | Br J Cancer | 2005 |